MTCR — Metacrine Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions
Brief: Metacrine And Equillium Mutually Agree To Terminate Definitive Merger Agreement
Brief: Braden Leonard Reports 15.2% Stake In Metacrine Inc
Metacrine Inc reports results for the quarter ended in September - Earnings Summary
Brief: Metacrine Inc Cash And Cash Equivalents Were $52.8 Million As Of Sept. 30
Brief: Metacrine Reports Third-Quarter 2022 Results
Metacrine Inc expected to post a loss of 10 cents a share - Earnings Preview
Metacrine up on buyout offer from Equillium
Brief: Equillium To Acquire Metacrine In All-Stock Transaction
Metacrine Inc reports results for the quarter ended in June - Earnings Summary
Metacrine Inc expected to post a loss of 25 cents a share - Earnings Preview
Metacrine Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Metacrine Reports Fourth-Quarter 2021 Results
Metacrine Inc expected to post a loss of 63 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Akamai Technologies, Metacrine, Vaxcyte
Metacrine, Inc. expected to post a loss of 61 cents a share - Earnings Preview